Veru Inc (VERU)
0.6294
+0.01
(+2.31%)
USD |
NASDAQ |
Nov 14, 16:00
0.6294
0.00 (0.00%)
After-Hours: 20:00
Veru Revenue (Quarterly): 3.954M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.954M |
| March 31, 2024 | 4.135M |
| December 31, 2023 | 2.141M |
| September 30, 2023 | 3.862M |
| June 30, 2023 | 3.341M |
| March 31, 2023 | 6.586M |
| December 31, 2022 | 2.508M |
| September 30, 2022 | 2.589M |
| June 30, 2022 | 9.602M |
| March 31, 2022 | 13.03M |
| December 31, 2021 | 14.14M |
| September 30, 2021 | 15.65M |
| June 30, 2021 | 17.66M |
| March 31, 2021 | 13.34M |
| December 31, 2020 | 14.62M |
| September 30, 2020 | 11.75M |
| June 30, 2020 | 10.32M |
| March 31, 2020 | 9.943M |
| December 31, 2019 | 10.58M |
| September 30, 2019 | 8.728M |
| June 30, 2019 | 9.727M |
| March 31, 2019 | 6.976M |
| December 31, 2018 | 6.372M |
| September 30, 2018 | 5.203M |
| June 30, 2018 | 5.502M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.573M |
| December 31, 2017 | 2.587M |
| September 30, 2017 | 3.692M |
| June 30, 2017 | 4.314M |
| March 31, 2017 | 2.406M |
| December 31, 2016 | 3.244M |
| September 30, 2016 | 3.563M |
| June 30, 2016 | 5.561M |
| March 31, 2016 | 4.773M |
| December 31, 2015 | 8.231M |
| September 30, 2015 | 7.155M |
| June 30, 2015 | 7.813M |
| March 31, 2015 | 10.98M |
| December 31, 2014 | 6.659M |
| September 30, 2014 | 5.554M |
| June 30, 2014 | 7.900M |
| March 31, 2014 | 4.346M |
| December 31, 2013 | 6.690M |
| September 30, 2013 | 4.789M |
| June 30, 2013 | 7.280M |
| March 31, 2013 | 9.477M |
| December 31, 2012 | 9.910M |
| September 30, 2012 | 9.912M |
| June 30, 2012 | 8.656M |
| March 31, 2012 | 7.831M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.141M
Minimum
Dec 2023
17.66M
Maximum
Jun 2021
8.933M
Average
9.943M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 3.721B |
| Scholar Rock Holding Corp | -- |
| Keros Therapeutics Inc | 0.388M |
| Biohaven Ltd | -- |
| Bioage Labs Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.97M |
| Total Expenses (Quarterly) | 15.00M |
| EPS Diluted (Quarterly) | -0.07 |
| Enterprise Value | 70.47M |
| Gross Profit Margin (Quarterly) | 33.84% |
| Profit Margin (Quarterly) | -277.4% |
| Earnings Yield | -47.66% |
| Normalized Earnings Yield | -50.71 |